Wealthy Nations Reap RSV Protection While Poorest Infants Are Left Behind, Global Model Warns
A global modelling study finds that the uneven rollout of nirsevimab and maternal RSV vaccination is concentrating benefits in high-income ...
A global modelling study finds that the uneven rollout of nirsevimab and maternal RSV vaccination is concentrating benefits in high-income ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine